The NUCKS1-SKP2-p21/p27 axis controls S phase entry

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Efficient entry into S phase is crucial for development and tissue repair.
• Uncontrolled S phase entry can lead to DNA damage and cancer.
• Strict regulation of the G1/S transition is vital for preventing oncogenesis.

Purpose of the Study:

• To identify and characterize a novel checkpoint pathway regulating the G1/S transition.
• To elucidate the molecular mechanisms integrating mitogenic and DNA damage signals for cell cycle control.
• To investigate the role of this pathway in cancer development and progression.

Main Methods:

• Chromatin recruitment assays to study NUCKS1 localization.
• Gene expression analysis to assess SKP2, p21, and p27 levels.
• Ubiquitin ligase assays to evaluate SCF^SKP2 activity.
• Analysis of The Cancer Genome Atlas (TCGA) data for cancer relevance.

Main Results:

• NUCKS1 acts as a transcription factor, promoting SKP2 expression upon mitogenic stimulation.
• SKP2 facilitates the degradation of cell cycle inhibitors p21 and p27, enabling S phase entry.
• DNA damage triggers p53-mediated repression of NUCKS1, leading to cell cycle arrest.
• The NUCKS1-SKP2-p21/p27 axis is frequently dysregulated in various cancers.

Conclusions:

• The NUCKS1-SKP2-p21/p27 axis serves as a critical checkpoint for the G1/S transition, integrating growth signals and DNA damage responses.
• Dysregulation of this pathway contributes to sustained proliferation in cancer by circumventing cell cycle arrest.
• Targeting this axis may offer therapeutic strategies for cancer treatment.